JOINT FILING AGREEMENT
Exhibit 99
In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Shares beneficially owned by each of them of Merus N.V. This Joint Filing Agreement shall be included as an Exhibit to such Schedule 13G.
The undersigned further agree that each party hereto is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein; provided that no party is responsible for the completeness or accuracy of the information concerning any other filing party, unless such party knows or has reason to believe that such information is inaccurate.
This Joint Filing Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original instrument, but all of such counterparts together shall constitute one agreement.
IN WITNESS WHEREOF, the undersigned hereby execute this Joint Filing Agreement as of the 2nd day of February, 2018.
|
|
|
|
|
|
|
|
/s/ Xxxx Xxxxxxxxx |
|
|
Name: Xxxx Xxxxxxxxx |
|
|
Title: Secretary of the Board |
|
|
|
|
|
/s/ Xxxxxxx Xxxxxxxxx |
|
|
Name: Xxxxxxx Xxxxxxxxx |
|
|
Title: Authorized Signatory |
|
|
|
|
|
Novartis AG |
|
|
|
|
|
/s/ Xxxx Xxxxxxxxx |
|
|
Name: Xxxx Xxxxxxxxx |
|
|
Title: Authorized Signatory |
|
|
|
|
|
/s/ Xxxxxxx Xxxxxxxxx |
|
|
Name: Xxxxxxx Xxxxxxxxx |
|
|
Title: Authorized Signatory |
